What’s Lurking in Diabetic Foot Wounds May Explain Treatment Failure
Novel agent ianalumab added to standard therapy extends time to treatment failure in patients with previously treated immune thrombocytopenia - EurekAlert!
New strategies reduce treatment failure in malaria by up to 81%
